← Back to Search

Other

Hyperbaric oxygen therapy for Coronavirus

Phase 2
Waitlist Available
Research Sponsored by Peter Lindholm
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This study is evaluating whether hyperbaric oxygen might help people with covid-19.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise tolerance
Secondary outcome measures
Dyspnea perception 1
Dyspnea perception 2
Excercise tolerance walk test
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hyperbaric oxygen therapyExperimental Treatment1 Intervention
Treatment with hyperbaric oxygen
Group II: ControlActive Control1 Intervention
Control, no treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen therapy
2013
Completed Phase 3
~1580

Find a Location

Who is running the clinical trial?

Peter LindholmLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela
Peter Lindholm 2021. "Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04905888.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top